We are live on ! Find out more
2

2Xideas Portfolio holdings

AUM $255M
1-Year Est. Return 0.46%
This Fund
S&P 500
This Quarter Est. Return
+11.12%
1 Year Est. Return
+0.46%
3 Year Est. Return
+33.96%
5 Year Est. Return
+43.71%
10 Year Est. Return
AUM
$742M
AUM Growth
-$58.6M
Cap. Flow
-$130M
Cap. Flow %
-17.5%
Top 10 Hldgs %
43.11%
Holding
57
New
6
Increased
4
Reduced
46
Closed
1

Top Buys

Rank Stock Value
1
FERG icon
Ferguson
FERG
+$13.9M
2
CSL icon
Carlisle Companies
CSL
+$8.1M
3
TECH icon
Bio-Techne
TECH
+$8.05M
4
BLD
TopBuild
BLD
+$8.03M
5
WCN
Waste Connections
WCN
+$7.92M

Top Sells

Rank Stock Value
1
ADI icon
Analog Devices
ADI
+$12.2M
2
TYL icon
Tyler Technologies
TYL
+$12M
3
HALO icon
Halozyme
HALO
+$11.1M
4
STZ icon
Constellation Brands
STZ
+$9.33M
5
ULTA icon
Ulta Beauty
ULTA
+$8.52M

Sector Composition

Rank Sector Weight
1 Healthcare 27.79%
2 Technology 25.79%
3 Financials 22.84%
4 Industrials 11.94%
5 Communication Services 4.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ICE icon
1
Intercontinental Exchange
ICE
$83.1B
$57M 7.68%
354,969
-26,833
-7% -$4.14M
FTNT icon
2
Fortinet
FTNT
$114B
$52.2M 7.03%
672,975
-39,855
-6% -$2.72M
IQV icon
3
IQVIA
IQV
$34.9B
$46.6M 6.28%
196,799
-9,101
-4% -$2.15M
PTC icon
4
PTC
PTC
$14.1B
$43.3M 5.83%
239,647
-17,739
-7% -$3.12M
RMD icon
5
ResMed
RMD
$29.1B
$32.8M 4.42%
134,257
-16,781
-11% -$3.75M
BAM icon
6
Brookfield Asset Management
BAM
$76.1B
$19M 2.56%
401,000
-44,600
-10% -$1.87M
RVTY icon
7
Revvity
RVTY
$12.3B
$18.2M 2.46%
142,644
-34,257
-19% -$4.03M
HALO icon
8
Halozyme
HALO
$9.87B
$17.5M 2.36%
305,587
-193,370
-39% -$11.1M
NYT icon
9
New York Times
NYT
$11.8B
$16.7M 2.25%
300,284
-131,418
-30% -$7.07M
RYAN icon
10
Ryan Specialty Holdings
RYAN
$5.51B
$16.6M 2.24%
250,637
-69,705
-22% -$4.35M
WSC icon
11
WillScot Mobile Mini Holdings
WSC
$4.88B
$16.6M 2.23%
440,828
-43,756
-9% -$1.67M
KNSL icon
12
Kinsale Capital Group
KNSL
$8.06B
$16M 2.16%
34,444
-2,209
-6% -$976K
ADSK icon
13
Autodesk
ADSK
$46.4B
$14.8M 2%
53,896
+10,628
+25% +$2.68M
EW icon
14
Edwards Lifesciences
EW
$47.3B
$14.8M 1.99%
224,082
+21,404
+11% +$1.56M
CSGP icon
15
CoStar Group
CSGP
$11.6B
$13.7M 1.85%
181,657
+62,670
+53% +$4.75M
FERG icon
16
Ferguson
FERG
$45.2B
$13.6M 1.83%
+68,437
New +$13.9M
ENTG icon
17
Entegris
ENTG
$19.2B
$12.5M 1.68%
111,037
+31,094
+39% +$3.68M
LNTH icon
18
Lantheus
LNTH
$7.07B
$10.5M 1.41%
95,569
-81,151
-46% -$8.43M
MKTX icon
19
MarketAxess Holdings
MKTX
$4.18B
$9.8M 1.32%
38,269
-13,317
-26% -$3.12M
COO icon
20
Cooper Companies
COO
$13.9B
$9.7M 1.31%
87,894
-24,043
-21% -$2.34M
POOL icon
21
Pool Corp
POOL
$6.7B
$9.41M 1.27%
24,969
-3,523
-12% -$1.22M
MSCI icon
22
MSCI
MSCI
$41.2B
$9.29M 1.25%
15,932
-4,325
-21% -$2.34M
AXP icon
23
American Express
AXP
$227B
$9.01M 1.21%
33,208
-16,077
-33% -$4M
ARES icon
24
Ares Management
ARES
$29.3B
$8.97M 1.21%
57,572
-26,601
-32% -$3.86M
LYV icon
25
Live Nation Entertainment
LYV
$41.7B
$8.96M 1.21%
81,856
-25,257
-24% -$2.44M

Similar funds

2Xideas's Q3 2024 Portfolio in Review

As of Q3 2024, 2Xideas held 57 positions worth $742M, down 7.3% from $801M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

2Xideas withdrew a net $130M in Q3 2024, closing 1 position and reducing 46 holdings. Its most notable exit was Ulta Beauty, an estimated $8.52M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 27% a quarter earlier, followed by Technology and Financials.

Against the trend, 2Xideas opened a new position in Ferguson worth $13.6M.

  • 2Xideas's largest Q3 2024 buy was Ferguson: 68,437 shares worth $13.6M.
  • 2Xideas added most to CoStar Group in Q3 2024, an estimated $4.75M increase.
  • 2Xideas's biggest Q3 2024 reduction was Analog Devices, cutting an estimated $12.2M.
  • 2Xideas fully exited Ulta Beauty in Q3 2024, selling an estimated $8.52M.
  • 2Xideas's ten largest holdings make up 43% of its $742M portfolio in Q3 2024.
  • 2Xideas opened 6 new positions and closed 1 in Q3 2024.
  • 2Xideas's portfolio value fell 7.3% quarter-over-quarter to $742M.

Based on 2Xideas's 13F filing for Q3 2024, filed 13 Nov 2024.